Should I buy Archrock, Inc. (AROC) stock or is it too late?
⭐ The most reliable of them, either direction: Mizuho — 62% of its targets hit on this sector (82 calls tested). It aims for $40 (+25 %), call made on June 4, 2026, maturing on June 4, 2027 (85 d ago).
Firm-by-firm track record on Archrock, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| RBC Capital | 90 % | +28.0 % | 10 | $46 +43% |
| B. Riley Securities | 40 % | +26.6 % | 5 | $9 -73% |
✅ Reasons to believe
- 100% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
- Median price target $40, i.e. +25% from the current price ($32).
- The most reliable firm on AROC, Evercore ISI Group (100% hit rate, 2 scored calls), targets $40 (call made on August 17, 2026, maturing on August 17, 2027) (+25%) in its most recent call, and $35 (call made on October 30, 2025, maturing on October 30, 2026) (+9%) in the one coming due soonest.
⚠️ Reasons to hesitate
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
- A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.
The analyst consensus on AROC
Median target $40 (+25%) · 5 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Archrock, Inc. now?
We won't decide for you. The facts: 100% of analysts rate it a buy, median target $40 (+25%), and Evercore ISI Group (most reliable on AROC, 100%) targets $40. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Archrock, Inc.?
Not according to analysts: the median target ($40) is still +25% above the current price ($32) (most reliable on AROC: Evercore ISI Group, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Archrock, Inc. still worth investing in?
It depends on the gap between the price ($32) and its estimated value: analysts target $40 on median (+25%), with 100% buys (most reliable on AROC: Evercore ISI Group, 100%). Cross-check with their real reliability on AROC and the cautions above. Information, not advice.
What's the main risk in buying AROC?
A 12-month target is not a guaranteed path: the price can fall in the meantime.
→ Go deeper: the full Archrock, Inc. profile (consensus, analyst reliability, price target, performance).